The persistence of Nontypeable Haemophilus Influenzae fuels type 17 immunity in the lung
F. Saliu (Milano (MI), Italy), G. Rizzo (Milano (MI), Italy), A. Bragonzi (Milano (MI), Italy), L. Cariani (Milano (MI), Italy), D. Cirillo (Milano (MI), Italy), C. Colombo (Milano (MI), Italy), V. Daccò (Milano (MI), Italy), D. Girelli (Milano (MI), Italy), S. Rizzetto (Milano (MI), Italy), C. Cigana (Milano (MI), Italy), N. Lore' (Milano (MI), Italy)
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Saliu (Milano (MI), Italy), G. Rizzo (Milano (MI), Italy), A. Bragonzi (Milano (MI), Italy), L. Cariani (Milano (MI), Italy), D. Cirillo (Milano (MI), Italy), C. Colombo (Milano (MI), Italy), V. Daccò (Milano (MI), Italy), D. Girelli (Milano (MI), Italy), S. Rizzetto (Milano (MI), Italy), C. Cigana (Milano (MI), Italy), N. Lore' (Milano (MI), Italy). The persistence of Nontypeable Haemophilus Influenzae fuels type 17 immunity in the lung. 2107
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: